ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.88
0.58%
US Tech 100
17,008.40
0.88%
S&P 500
5,053.77
0.71%
US Dollar vs CAD
1.36865
-0.27%
Bitcoin
59,086.44
1.46%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cassava Sciences Inc (SAVA)

  7. Cassava Sciences Inc (SAVA) News

SAVA Cassava Sciences Inc

22.03
-0.11 (-0.50%)
Last Updated: 12:36:23
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cassava Sciences Inc SAVA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.11 -0.50% 22.03 12:36:23
Open Price Low Price High Price Close Price Previous Close
22.20 21.89 22.25 22.14
more quote information »

Recent News

Date Time Source Heading
5/01/202408:10GLOBETomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
4/15/202408:20GLOBERedemption Date Announced for Warrants
3/25/202408:13GLOBECassava Sciences Announces Completion of an Interim Safety..
3/04/202408:15GLOBECassava Sciences Announces Virtual Presentation at the..
2/28/202415:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/28/202408:22EDGAR2Form 8-K - Current report
2/28/202408:14GLOBECassava Sciences Reports Full-year 2023 Financial Results..
2/07/202408:20EDGAR2Form 8-K - Current report
2/07/202408:08GLOBENo Decline in Cognition Scores in Patients with Mild..
2/01/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/26/202415:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/05/202408:12GLOBECassava Sciences Completes Dividend Distribution of Warrants..
1/03/202415:24EDGAR2Form CERT - Certification by an exchange approving..
1/03/202415:22EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
1/03/202415:18EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
1/03/202408:10EDGAR2Form 8-K - Current report
1/02/202408:10EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
12/12/202308:19EDGAR2Form 8-K - Current report
12/12/202308:13GLOBECassava Sciences Announces Dividend Distribution of Warrants..
12/11/202315:18EDGAR2Form 8-K - Current report
12/08/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202315:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202315:01GLOBECassava Sciences Appoints Three New Members to its Board of..
11/07/202308:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202308:08EDGAR2Form 8-K - Current report
11/07/202308:01GLOBECassava Sciences Reports Third Quarter 2023 Financial and..
11/06/202308:15GLOBECassava Sciences Completes Enrollment for Pivotal Phase 3..
10/25/202308:15GLOBEMRI Data Suggest Simufilam is Not Associated with..
10/13/202308:06IHMARKETNEWSFriday’s Wall Street Highlights: Dollar General, Microsoft,..
10/12/202322:43GLOBEStatement by Cassava Sciences Regarding an Internal CUNY..
10/05/202308:15GLOBECassava Sciences to Present at the Jefferies Biotech..
10/04/202317:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202317:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202317:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202308:00GLOBECassava Sciences Completes Patient Enrollment for Pivotal..
9/18/202308:15GLOBECassava Sciences Announces Positive Interim Safety Review of..
9/13/202315:17EDGAR2Form 8-K - Current report
9/11/202308:10GLOBECassava Sciences Announces Science Publication That Confirms..
9/06/202308:15GLOBECassava Sciences Invited to Present in Four Upcoming..
8/24/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/23/202315:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/03/202315:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202308:12EDGAR2Form 8-K - Current report
8/03/202308:07GLOBECassava Sciences Reports Q2 2023 Financial Results and..
7/05/202308:25EDGAR2Form 8-K - Current report
7/05/202308:15GLOBEOral Simufilam Slowed Cognitive Decline in a Randomized..
6/27/202308:15GLOBENew Research Shows Simufilam Suppresses Overactive mTOR
6/12/202308:15GLOBENew Publication Highlights Basic Science Supporting..

Your Recent History

NASDAQ
SAVA
Cassava Sciences
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved